Ex-Merck VP Says Investors 'Overstate' Omnicare Impact
By Stephanie Russell-Kraft · March 31, 2015, 4:50 PM EDT
Attorneys for a former Merck & Co. Inc. vice president accused of lying about study results on Vioxx's heart attack link told a New Jersey federal court Tuesday that, contrary to...
To view the full article, register now.